First in Chicago
The University of Chicago was the first hospital in the Chicago area to offer a pediatric bone marrow transplant program more than 20 years ago. Experience, scientific study and innovations continue to add to the applications for this treatment and to the steadily increasing survival rates.
Nationally Recognized Experts
Our experts are nationally recognized leaders in the research and development of novel uses for this life-saving treatment. For example, we are now offering a new technique that refines blood stem cell grafts from parents, making them suitable donors for their own children. This unique approach couples state-of-the-art stem cell purification technologies with novel chemotherapy and/or radiation therapy regimens to reduce toxicity, while ensuring long-term graft viability and a reduction in the incidence of disease relapse.
New purification technique expands donor pool to include parents.
In children with leukemia and other malignant diseases, the latter complication is treated by a combination of changes in immune suppression medications and infusion of selected cell populations that target the malignant cells.